Daniel K. Hall‐Flavin
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
Papers in
-
- Tryptophan and brain disorders 6
-
- Treatment of Major Depression 5
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Joanna M. Biernacka (21 shared papers)David A. Mrazek (16 shared papers)Joel G Winner (4 shared papers)Josiah D. Allen (4 shared papers)Jennifer R. Geske (13 shared papers)Mark A. Frye (19 shared papers)Victor M. Karpyak (22 shared papers)Terry D. Schneekloth (18 shared papers)
- Journals
- American Journal on Addictions (7 papers)Translational Psychiatry (5 papers)Molecular Psychiatry (4 papers)Mayo Clinic Proceedings (3 papers)Journal of Affective Disorders (2 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Daniel K. Hall‐Flavin
50 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 129
- Biological Psychiatry 270
- Pharmacology 373
- Behavioral Neuroscience 103
- Pharmacology 342
- Psychiatry and Mental health 285
Countries citing papers authored by Daniel K. Hall‐Flavin
This map shows the geographic impact of Daniel K. Hall‐Flavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel K. Hall‐Flavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel K. Hall‐Flavin more than expected).
Fields of papers citing papers by Daniel K. Hall‐Flavin
This network shows the impact of papers produced by Daniel K. Hall‐Flavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel K. Hall‐Flavin. The network helps show where Daniel K. Hall‐Flavin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel K. Hall‐Flavin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 165 | |
| 2 | 2012 | 158 | |
| 3 | 2020 | 145 | |
| 4 | 2015 | 110 | |
| 5 | 2016 | 104 | |
| 6 | 2015 | 96 | |
| 7 | 2020 | 90 | |
| 8 | 2012 | 79 | |
| 9 | 2015 | 75 | |
| 10 | 2019 | 75 | |
| 11 | 2016 | 74 | |
| 12 | 2018 | 70 | |
| 13 | 2014 | 70 | |
| 14 | 2019 | 62 | |
| 15 | 2015 | 62 | |
| 16 | 2016 | 54 | |
| 17 | 2013 | 51 | |
| 18 | 2014 | 50 | |
| 19 | 2010 | 45 | |
| 20 | 2014 | 41 |
About Daniel K. Hall‐Flavin
Daniel K. Hall‐Flavin is a scholar working on Biological Psychiatry, Pharmacology, Psychiatry and Mental health, Epidemiology and Pathology and Forensic Medicine, having authored 51 papers that have together received 2.2k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (10 papers), Alcohol Consumption and Health Effects (6 papers), Tryptophan and brain disorders (6 papers), Treatment of Major Depression (5 papers), Genetic Associations and Epidemiology (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Schizophrenia research and treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Biological Psychiatry (270 citations), Pharmacology (373 citations), Behavioral Neuroscience (103 citations), Pharmacology (342 citations) and Psychiatry and Mental health (285 citations). Daniel K. Hall‐Flavin has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Joanna M. Biernacka, David A. Mrazek, Joel G Winner, Josiah D. Allen, Jennifer R. Geske, Mark A. Frye, Victor M. Karpyak, Terry D. Schneekloth, Maureen S. Drews and Joseph M. Carhart. Their work appears in journals such as American Journal on Addictions, Translational Psychiatry, Molecular Psychiatry, Mayo Clinic Proceedings and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.